Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23992515 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium 18 mcg;   Drug: tiotropium 1.25 mcg (2 actuations/day);   Drug: tiotropium 2.5 mcg (2 actuations/day)

Indicates status has not been verified in more than two years